Erratum: Role of the lysine-specific demethylase 1 in the proinflammatory phenotype of vascular smooth muscle cells of diabetic mice (Circulation Research (2008) 103 (615-623) DOI: 10.1161/CIRCRESAHA.108.175190);Role of the lysine-specific demethylase 1 in the proinflammatory phenotype of vascular smooth muscle cells of diabetic mice

Circulation Research

Volumn 103, Issue 6, 2008, Pages 615-623

  Reddy, Marpadga A ^a   Villeneuve, Louisa M ^a   Wang, Mei ^a   Lanting, Linda ^a   Natarajan, Rama ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Atherosclerosis; Diabetes; Histone modifications; Inflammation vascular smooth muscle cells

Indexed keywords

GLUCOSE; HISTONE H3; INTERLEUKIN 6; LYSINE; LYSINE SPECIFIC DEMETHYLASE1; MONOCYTE CHEMOTACTIC PROTEIN 1; RNA POLYMERASE II; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AUTACOID; HISTONE; LSD1 PROTEIN, MOUSE; N DEMETHYLASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; DIABETES MELLITUS; EPIGENETICS; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; INFLAMMATION; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN METHYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; ANIMAL; COMPARATIVE STUDY; ENZYMOLOGY; GENETICS; METABOLISM; METHYLATION; MOUSE MUTANT; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; PHYSIOLOGY;

ANIMALS; DIABETES MELLITUS, TYPE 2; HISTONES; HUMANS; INFLAMMATION MEDIATORS; LYSINE; MALE; METHYLATION; MICE; MICE, KNOCKOUT; MICE, MUTANT STRAINS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OXIDOREDUCTASES, N-DEMETHYLATING; PHENOTYPE;

EID: 53249108053     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/RES.0b013e3181bc3a4d     Document Type: Erratum

References (40)

1. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006;116:1793-1801.
2. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813-820.
3. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;52:1685-1695.
4. Natarajan R, Nadler JL. Lipid inflammatory mediators in diabetic vascular disease. Arterioscler Thromb Vasc Biol. 2004;4:1542-1548.
5. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemic damage. Nature. 2000;404:787-790.
6. Dandona P, Aljada A, Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol. 2005;25:4-7.
7. Ramasamy R, Vannucci SJ, Yan SS, Herold K, Yan SF, Schmidt AM. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology. 2005;15: 16R-28R.
8. Das Evcimen N, King GL. The role of protein kinase C activation and the vascular complications of diabetes. Pharmacol Res. 2007;55:498-510.
9. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135-1143.
10. Raines EW, Ferri N. Cytokines affecting endothelial and smooth muscle cells in vascular disease. J Lipid Res. 2005;46:1081-1092.
11. Natarajan R, Gonzales N, Xu L, Nadler J. Vascular smooth muscle cells exhibit increased growth response to elevated glucose. Biochem Biophys Res Commun. 1992;87:552-560.
12. Natarajan R, Bai W, Rangarajan V, Gonzales N, Gu J-L, Linda L, Nadler JL. Platelet-derived growth factor-BB-mediated regulation of 12-lipoxy-genase in porcine aortic smooth muscle cells. J Cell Physiol. 1996;169: 391-400.
13. Yasunari K, Kohno M, Kano H, Yokokawa K, Minami M, Yoshikawa J. Mechanisms of action of troglitazone in the prevention of high glucose-induced migration and proliferation of cultured coronary smooth muscle cells. Circ Res. 1997;81:953-962.
14. Sakaguchi T, Yan SF, Yan SD, Belov D, Rong LL, Sousa M, Andrassy M, Marso SP, Duda S, Arnold B, Liliensiek B, Nawroth PP, Stern DM, Schmidt AM, Naka Y. Central role of RAGE-dependent neointimal expansion in arterial restenosis. J Clin Invest. 2003;111:959-972.
15. Reddy MA, Li SL, Sahar S, Kim YS, Xu ZG, Lanting L, Natarajan R. Key role of SRC kinase in S100B-induced activation of the receptor for advanced glycation end products in vascular smooth muscle cells. J Biol Chem. 2006;281:13685-111369
16. Li S-L, Reddy MA, Cai Q, Meng L, Yuan H, Lanting L, Natarajan R. Enhanced pro-atherogenic responses in macrophages and vascular smooth muscle cells derived from diabetic db/db mice. Diabetes. 2006; 55:2611-2619.
17. Hatley ME, Srinivasan S, Reilly KB, Bolick DT, Hedrick CC. Increased production of 12/15 lipoxygenase eicosanoids accelerates monocyte/en-dothelial interactions in diabetic db/db mice. J Biol Chem. 2003;278: 25369-25375.
18. Wen Y, Gu J, Li SL, Reddy MA, Natarajan R, Nadler JL. Elevated glucose and diabetes promote interleukin-12 cytokine gene expression in mouse macrophages. Endocrinology. 2006;147:2518-2525.
19. Berger SL. Histone modifications in transcriptional regulation. Curr Opin Genet Dev. 2002;12:142-148.
20. Strahl BD, Allis CD. The language of covalent histone modifications. Nature. 2000;403:41-45.
21. Shilatifard A. Chromatin modifications by methylation and ubiquiti-nation: implications in the regulation of gene expression. Annu Rev Biochem. 2006;75:243-269.
22. Jenuwein T, Allis CD. Translating the histone code. Science. 2001;293: 1074-1079.
23. Nightingale KP, O'sNeill LP, Turner BM. Histone modifications: signalling receptors and potential elements of a heritable epigenetic code. Curr Opin Genet Dev. 2006;16:125-136.
24. Shi Y, Lan F, Matson C, Mulligan P, Whetstine JR, Cole PA, Casero RA, Shi Y. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell. 2004;119:941-953.
25. Metzger E, Schüle R. The expanding world of histone lysine dem-ethylases. Nat Struct Mol Biol. 2007;14:252-254.
26. Stavropoulos P, Blobel G, Hoelz A. Crystal structure and mechanism of human lysine-specific demethylase-1. Nat Struct Mol Biol. 2006;13: 626-632.
27. Shi YJ, Matson C, Lan F, Iwase S, Baba T, Shi Y. Regulation of LSD1 histone demethylase activity by its associated factors. Mol Cell. 2005;19: 857-864.
28. Lee MG, Wynder C, Cooch N, Shiekhattar R. An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation. Nature. 2005; 437:432-435.
29. Cai Q, Lanting L, Natarajan R. Interaction of monocytes with vascular smooth muscle cells regulates monocyte survival and differentiation through distinct pathways. Arterioscler Thromb Vasc Biol. 2004;24: 2263-2270.
30. Martin C, Zhang Y. The diverse functions of histone lysine methylation. Nat Rev. 2005;6:838-849.
31. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353: 2643-2653.
32. Ihnat MA, Thorpe JE, Ceriello A. Hypothesis: the 'smetabolic memory's, the new challenge of diabetes. Diabet Med. 2007;24:582-586.
33. Ihnat MA, Thorpe JE, Kamat CD, Szabó C, Green DE, Warnke LA, Lacza Z, Cselenyák A, Ross K, Shakir S, Piconi L, Kaltreider RC, Ceriello A. Reactive oxygen species mediate a cellular 'smemory's of high glucose stress signalling. Diabetologia. 2007;50:1523-1531.
34. Miao F, Gonzalo IG, Lanting L, Natarajan R. In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions. J Biol Chem. 2004;279:18091-18097.
35. Miao F, Li S, Chavez V, Lanting L, Natarajan R. Coactivator-associated arginine methyltransferase-1 enhances nuclear factor-kappaB-mediated gene transcription through methylation of histone H3 at arginine 17. Mol Endocrinol. 2006;20:1562-1573.
36. Yerneni KK, Bai W, Khan BV, Medford RM, Natarajan R. Hyperglycemia- induced activation of nuclear transcription factor kappaB in vascular smooth muscle cells. Diabetes. 1999;48:855-864.
37. Beausoleil SA, Jedrychowski M, Schwartz D, Elias JE, Villén J, Li J, Cohn MA, Cantley LC, Gygi SP. Large-scale characterization of HeLa cell nuclear phosphoproteins. Proc Natl Acad Sci U S A. 2004;101: 12130-12135.
38. Rechsteiner M, Rogers SW. PEST sequences and regulation by prote-olysis. Trends Biochem Sci. 1996;21:267-271.
39. Santos-Rosa H, Caldas C. Chromatin modifier enzymes, the histone code and cancer. Eur J Cancer. 2005;14:2381-2402.
40. Kahl P, Gullotti L, Heukamp LC, Wolf S, Friedrichs N, Vorreuther R, Solleder G, Bastian PJ, Ellinger J, Metzger E, Schüle R, Buettner R. Cancer Res. 2006;66:1341-11347.